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Plasma membrane calcium-ATPase isoform four distribution
changes during corneal epithelial wound healing
Ernest F. Talarico Jr.
Department of Anatomy & Cell Biology, Indiana University School of Medicine-Northwest, Gary, IN
Purpose: Plasma Membrane Calcium-ATPases (PMCAs) are integral membrane proteins essential to the control of
intracellular Ca2+ concentration. In humans, four genes encode PMCA proteins termed PMCA1-PMCA4. PMCA4 is the
major PMCA isoform expressed in human corneal epithelium (hCE); however, little is known about its role. The present
study documented expression of PMCA4 in rabbit CE (rbCE) and followed the distribution of PMCA4 during CE wound
healing in a rabbit (rb) model.
Methods: Reverse transcriptase PCR using PMCA4 isoform gene-specific primers that flanked alternative splice site A
was used to examine the presence of PMCA4 mRNA in rbCE. Protein expression was assessed by immunoblotting using
panPMCA-  and  PMCA4-specific  antibodies.  Immunocytochemistry  was  employed  to  examine  PMCA
immunolocalization in frozen, formaldehyde-fixed sections of control and wounded rb corneas. In wound healing studies,
circular, 6-mm diameter corneal wounds were produced in the central CE using the n-heptanol technique. The distribution
of PMCA4 in CE was examined by immunohistochemical staining of frozen sections using PMCA4 isoform-specific
antibody at 6-, 24-, 36-, and 48 h post-injury. siRNAPMCA4 was used to transfect telomerase-immortalized human corneal
epithelial (hTCEpi) cells. Cell cultures were wounded 48 h after transfection, and the wound area was measured at 0 h
and at 3 h intervals post-wounding.
Results: Direct sequencing of PCR DNAs documented the presence of PMCA4 transcripts in rbCE and showed that the
splice variant at site A was PMCA4x. Immunoblot analysis for PMCA4 detected an intense band at approximately 160 kDa
and a faint band at approximately 142 kDa. Immunohistochemistry with the panPMCA antibody demonstrated strong
immunoreactivity  (IR)  in  all  layers  of  uninjured  rbCE.  Immunohistochemistry  with  a  PMCA4-specific  antibody
demonstrated a similar pattern of intense IR along the plasma membrane of cells in all layers of CE, except for the notable
absence of PMCA4 IR along the basal cell membranes adjacent to the stroma. The pattern of PMCA4 IR changed following
wound healing. During the lag phase of corneal epithelial wound healing, PMCA4 IR was seen mostly on apical plasma
membranes of basal cells near the wound margin, with little staining of basal plasma membranes. During the migration
phase (24 h), PMCA4 IR was found mostly on basal cell membranes adjacent to the stroma. At 6 h and 24 h following
wounding, PMCA4 IR of the cytoplasm was increased compared to control eyes. After closure of the denuded area and
stratification, PMCA4 IR was again primarily found along the apical and lateral plasma membranes of basal cells and was
again absent from basal cell membranes adjacent to the stroma; PMCA4 IR of the cytoplasm was also similar to that
observed in control eyes. siRNAPMCA4 transfected hTCEpi cells failed to seal the wound area, whereas wounds in control
cultures transfected with a scrambled construct were completed healed.
Conclusions:  PMCA4  is  strongly  expressed  in  rabbit  CE  and  its  immunolocalization  exhibits  marked  changes  in
distribution during the wound healing process. Knockdown of PMCA4 expression in hTCEpi cells decreases wound
healing. Present findings suggest that PMCA4 redistribution could function as one factor in mediating calcium-regulated
events necessary for cell migration in regenerating CE.
The corneal epithelium (CE) after artificial wounding
provides a valuable model to study the migration of stratified
epithelial cells in vivo. The CE is a nonkeratinized stratified
squamous epithelium that covers the anterior surface of the
cornea [1-4]. It consists of 2–3 layers each of superficial
squamous cells and intermediate wing cells, and a single layer
of basal cells next to the corneal stroma [5]. Basal cells are the
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only  corneal  epithelial  cells  capable  of  proliferating,  and
provide a continuous supply of new cells to replace terminally
differentiated  cells  lost  from  the  superficial  layer  during
desquamation and eye blinking [5-7].
CE exhibits a highly developed ability to repair itself
following wounding; thus, providing a mechanism to quickly
re-establish integrity of its critical barrier functions [8]. The
process of corneal epithelial wound closure is essentially a
biphasic process comprised of an initial latent phase and a
subsequent cell migration phase [9,10]. The latent phase lasts
approximately 4–6 h, during which time cellular mitosis and
DNA synthesis are nearly halted [11-13] and epithelial cells
at  the  wound  margin  undergo  extensive  cellular  and
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2259subcellular reorganization as they prepare to migrate into the
defect. By 6 h post injury, basal cells near the wound margin
have lost their columnar appearance and have broken many
of their hemisdesmosomal attachments to the basal lamina
[10].  In  addition,  cells  at  the  wound  margin  become
exceedingly thin and exhibit filopodia and ruffled boarders
typical  of  migrating  cells  [10].  The  latent  phase  is  then
followed by a migration phase that is characterized by a burst
of proliferative activity in more peripheral basal cells [11,
13], and concurrent migration of cells at the wound margin
into the denuded area. The cells at the leading edge pull more
peripheral cells behind them as a continuous epithelial sheet
until the wound defect is covered by a monolayer of cells
[14-17]. Increased proliferative activity continues above basal
level for approximately 2–7 days until the full thickness of the
CE is re-established [18].
The  process  of  CE  wound  healing  is  complex  and
involves  a  coordinated  sequence  of  physiologic  events
including  cell  migration,  proliferation  and  differentiation
[18,19], all of which depend on calcium-mediated processes.
For  example,  both  intracellular  and  extracellular  Ca2+
concentrations  regulate  integrin-mediated  adhesion  during
cell migration [20]. Ca2+ and the calcium-binding protein,
calmodulin (CaM), are needed for cells to enter the synthesis
(S) phase of proliferation [21-24]. Cell differentiation and
adhesion are also dependent upon [Ca2+]i [20,25].
One  of  the  principle  enzymes  regulating  intracellular
Ca2+  concentration  is  plasma  membrane  Ca2+-ATPase
(PMCA). PMCAs are present in the surface membranes of
cells  and  extrude  Ca2+  against  very  large  concentration
gradients [26,27]. In humans, four genes known as ATP2B1-
ATP2B4 encode PMCA proteins termed PMCA1-PMCA4,
respectively  [28-32].  PMCA1  and  PMCA4  are  expressed
ubiquitously [30,33-36], whereas PMCA2 and PMCA3 are
distributed in a tissue-specific fashion with PMCA2 expressed
preferentially in brain and cardiac muscle and PMCA3 in
brain and skeletal muscle [37,38]. PMCA isoform diversity is
further increased via alternative splicing of primary RNA
transcripts [30,33,38,39] that could result in more than 25
distinct  proteins  [38,40].  This  diversity  and  the  complex
nature of temporal and spatial isoform expression suggest that
the physiologic function of PMCAs extends beyond simply
maintaining low [Ca2+]i [28,36,37,39].
It has been shown that during the migration phase of
mouse CE wound healing, PMCAs redistribute from plasma
membrane  caveolae  to  membranous  structures  in  the
cytoplasm. PMCAs then returned to the plasma membrane
when the defect was healed [41,42]. This is significant in that
many  of  the  processes  that  occur  during  wound  healing
involve Ca2+ as messenger or trigger, including synthesis of
proteins and glycoproteins [43], glycogen metabolism [44],
and actin filament reorganization and podial extension [9,45,
46]. Redistribution of PMCAs suggests that regional changes
in [Ca2+]i may occur during the wound healing process, and
that  changes  in  [Ca2+]i  could  function  in  the  regulatory
programs that direct changes in cell motility, morphology and
adhesion.
Prior  studies  in  our  laboratory  have  determined  the
expression of PMCA splice variants and their distribution in
native  human  corneal  epithelium  [47,48].  These  results
showed that PMCA4 was the predominant isoform in human
CE,  and  that  PMCA4  was  localized  to  the  epithelial  cell
plasma membranes in all layers of CE.
Critically, there was lack of PMCA4 immunoreactivity
along the portion of the plasma membranes of basal cells
adjacent to the underlying stroma. Because basal cells in CE
are the only cells in CE capable of mitosis and CE wound
repair, and the localization of PMCA4 differs in basal cells
compared to the other cell types (i.e., wing and squamous) that
comprise CE, we hypothesized that PMCA4 would be a good
“candidate PMCA” to study. Thus, in the present work, we
investigated the localization of PMCA4 during CE wound
healing in a rabbit (rb) model. We report here that during CE
wound healing, PMCA4 redistributes in the plasma membrane
of CE cells at the wound margin and returns to its normal
distribution soon after the wound is closed. We hypothesize
that PMCA4 redistribution is a factor in mediating calcium-
regulated events necessary for cell migration in regenerating
CE.
METHODS
Experiments were conducted according to the guidelines of
Indiana University School of Medicine and in compliance
with federal regulations governing the use and protection of
animal subjects in research. A total of 14 male, New Zealand
albino  rabbits,  approximately  4–5  pounds  each,  were
purchased from Kuiper Rabbit Ranch (Gary, IN) for use in
this study.
Immunoblotting:  CE  from  three  normal  rabbits  was
removed by mechanical scraping with a No. 10 scalpel blade
while the cornea was immersed in ice-cold 0.1 M PBS (0.084
M  Na2HPO4,  0.016  M  KH2PO4,  0.9%  NaCl).  Sample
preparation, electrophoresis, and immunoblotting were done
as previously described [47]. Briefly, cells were placed into a
conical centrifuge tube, suspended by gentle pipetting, and
centrifuged for 7 min. The cell pellet was resuspended and
washed in PBS. An aliquot was removed for determination of
total protein concentration, and the remaining suspension was
solubilized in electrophoresis sample buffer. CE samples and
molecular weight standards were resolved by SDS-PAGE
using  a  Laemmli  system  with  an  8%  gel.  Proteins  were
transferred to PVDF membranes (Immobilon-P; Millipore,
Burlington, MA) by semi-dry electroblotting.  Blots were wet
with MeOH, washed using a high salt Tris Buffered Saline
Solution (HTBS), and blocked at room temperature (RT). 
After  a  wash  in  HTBS,  blots  were  reacted  with  primary
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2260antibody RT.  The blots were then washed, blocked a second
time, and incubated for RT with secondary antibody. The blots
were then washed four times in HTBS, and incubated for 30
min at RT in CDP-Star chemiluminescent substrate (Applied
Biosciences, Bedford, MA) in order to visualize the cross-
reacting bands. The chemiluminescent signal was captured
using a Kodak Image Station 440CF (Kodak, Rochester, NY).
Sequence  determination  of  PMCA4  alternative  splice
variants: CE removed by mechanical scraping was stored in
RNALaterTM (Ambion, Austin, TX). The tissue was weighed
and total RNA was extracted using an RNAqueous-4PCR Kit
(Ambion).  The  RNA  concentration  was  determined  by
spectrophotometric (260 nm versus 280 nm) analysis.
Total RNA extracts were used for reverse transcription
(RT) using the SuperScriptTM First Strand Synthesis for RT–
PCR Kit (Invitrogen, Carlsbad, CA). PCR was done using the
High Fidelity PCR Master Kit (Roche, Roche Diagnostics,
Mannheim, Germany) with 1 μl cDNA template and 1 μl 400
nM  each  of  forward  and  reverse  PMCA4  isoform  gene-
specific primer. The primer set for PMCA4 (Invitrogen, Life
Technologies, Grand Island, NY) flanks alternative splice site
A [38,49], and has been successfully used in prior research in
our laboratory [50,51]. The forward primer, pmca4apa has the
sequence 5′-TAC TCT CTT GGG GGT CAA TGA-3′, and a
starting  position  at  residue  1,736.  The  reverse  primer,
pmca4ama, has the sequences 5′-CCA TGG TCT GCG ATT
TAT CAC A-3′, and a starting position of 2,066. Reactions
were amplified using a GeneAmp PCR System 2000 (Applied
Biosciences).  The  following  cycling  conditions  were
employed: initial denaturation at 94 °C (2 min), 10 cycles of
94 °C (15 s), 55 °C (30 s) and 72 °C (40 s), 25 cycles of 94 °C
(15 s), 55 °C (30 s) and 72 °C (40 s increased by 20 s per
cycle), then a final extension at 72 °C (7 min), and a hold at
4  °C  [51].  Aliquots  of  PCR  products  and  PCR  markers
(Promega,  Madison,  WI)  were  electrophoresed  in  2.0%
agarose gel in 1X TAE Buffer using Rapid Acrylamide Gel
Electrophoresis (RAGE) at 210 V for 8 min, and visualized
using an Ultraviolet Transilluminator (Ultraviolet Products,
Upland,  CA)  connected  to  a  Kodak  Electrophoresis
Documentation/Analysis  Imaging  system  (EDAS290;
Kodak).
PCR DNAs were purified using the Wizard® PCR Preps
DNA  Purification  System  (Promega)  and  Vac-Man®  Jr.
Laboratory Vacuum Manifold (Promega). Purified samples of
PMCA PCR DNAs were submitted for direct sequencing to
the Cancer Research Center DNA Sequencing Facility at the
University of Chicago. The sequences were analyzed using
Chromas V2.11 (Technelysium Pty. Ltd., Tewantin QLD,
Austrailia). Edited sequences were aligned and translated for
determination  of  amino  acid  sequence  using  the  Baylor
College  of  Medicine  Search  Launcher-Multiple  Sequence
Alignment Program (Baylor College of Medicine, Baylor,
TX). DNA and amino acids sequences were compared to
known  sequences  using  the  National  Center  for
Biotechnology Information Nucleotide BLAST and Protein/
Translated Sequence Blast, respectively, and ExPASy was
also used for the determination of translated sequences.
Corneal  epithelial  wounding  protocol:  Rabbits  were
deeply  anesthetized  with  2.5%  Pentothal  (Fort  Dodge®
Animal Health, Fort Dodge, IA) administered via a lateral
marginal ear vein. A unilateral circular wound was produced
in the central CE of the experimental (left) eye using the n-
heptanol technique [52]. Briefly, the eye was proptosed by
applying  gentle  pressure  behind  the  globe  and  a  6.5  mm
diameter  Wratten  No.1  filter  paper  disc  saturated  with  n-
heptanol was gently pressed against the central cornea for 30
s. The disc was then removed and the cornea was rinsed with
10 ml of warm, sterile saline. This protocol produces a well
defined, circular epithelial defect with little or no damage to
the underlying corneal stroma [52]. Prior work has shown that
corneal  wounds  produced  by  this  method  typically  heal
completely within 2–3 days [16,52]. The control [53] eye of
each experimental animal was treated in an identical fashion
except  that  0.1  M  PBS  (0.084  M  Na2HPO4,  0.016  M
KH2PO4, 0.9% NaCl) was substituted for the n-heptanol. The
animals were examined at regular postoperative intervals for
any signs of squinting, ocular redness, or infection.
At  6,  24,  36,  and  48  h  post-wounding  (there  were  3
animals at each time point, respectively, the third animal for
the 48 h post-wounding time point had to be prematurely
sacrificed due to eye infection.), animals were euthanized with
1.5 ml of Sleepaway (Sodium Pentobarbital 26%, isopropyl
alcohol 7.8%, Fort Dodge® Animal Health). Wounded and
control corneas were harvested from each animal, placed in
ice-cold 0.1 M PBS, and cleaned of all excess tissue except
for a thin rim (~1.0 mm) of sclera. The center of each cornea
was marked and the corneas were cut into quadrants using a
sterile No. 10 scalpel blade. The quadrants were immersion-
fixed for 30 min at room temperature in 4% paraformaldehyde
containing 0.2% picric acid and 2% sucrose, pH 7.3, and then
passed through a series of sucrose solutions (5%, 10%, 20%,
and 30% sucrose in 0.1 M PBS) for at least 1 h each at 4 °C.
Tissues were stored in ice-cold 30% sucrose-0.02% sodium
azide containing 0.1 M PBS until sectioned.
siRNA experiments: hTCEpi cells were provided by Jerry
W.  Shay,  Department  of  Cell  Biology,  UT  Southwestern
Medical  Center  (Dallas,  TX).  These  cells  have  been
characterized for use in CE cell culture experiments [54].
hTCEpi cells were seeded onto primaria-coated, 6-well plates
at a concentration of 3.0 × 104 cells/well and grown to form
confluent monolayers in KBM-2 media (KBM-2 Bullet Kit,
#CC3170; Lonza, Walkersville, MD). Media was aspirated
and “naked” siRNA transfection was done in separate wells
using a 30 nM final concentration in 2.0 ml of KBM-2 media
of siRNAPMCA4 construct for Exon 17 of PMCA4 (Ambion)
and  a  siRNAScrambled  construct  (Ambion)  with  no  known
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2261homologous targets in human CE cells. The sequence (5′→3′)
for the siRNAPMCA4 construct was 5′-GCA CUA UAC CAU
UGU UUU Utt-3′ (sense) and 5′-AAA AAC AAU GGU AUA
GUG Ctg-3′ (antisense). siRNAScrambled construct was supplied
in  the  siRNA  Transfection  Kit  II  (Ambion).  The  final
concentration of siRNA used was determined as described in
the  siRNA  Transfection  Kit.  At  48  h  post-transfection,
cultures were wounded by dragging a sterile 200 μl pipette tip
across the surface of the well, and the cultures were washed 3
times with KBM-2 media, and then 2.0 ml of KBM-2 media
was added to each culture. Photomicrographs were taken at 0
h and at 3 h intervals thereafter for a total of 30 h. The wound
area measured using AxioVision Software R6.2 (Carl Zeiss,
Inc., Göttingen, Germany). The calculated wound area was
normalized to 0 h, and plotted as wound area versus time post-
wounding. A total of 9 wells each for siRNAPMCA4 and for
siRNAScrambled  transfected  cultures  were  done.  Statistical
analysis for standard error and t-test with p-values were done
using Excel 2010 (Microsoft Office, Microsoft Corporation,
Redmond, WA).
Immunohistochemistry: Immediately before sectioning,
a 1 mm – wide rectangular piece of tissue was cut from one
edge  of  each  quadrant  and  placed  into  OTC  Compound
(Tissue-Tek®; Sakura Finetechnical Co., Tokyo, Japan) for 20
min and then frozen. Sections perpendicular to the corneal
surface were cut at eight microns on a Minitome cryostat
(International Equipment Corporation, Needham, MA) and
collected onto chrome-alum-gelatin coated slides.
Sections were washed three times in 0.1 M PBS at RT,
permeabilized  for  20  min  in  ice-cold  methanol,  and  then
washed three times in 0.1 M PBS – 0.3% Triton X-100 (TX).
Sections were incubated for 20 min at RT in 10% normal horse
serum (Vector Laboratories, Burlingame, CA) in 0.1 M PBS
– 0.3% TX. Alternate slides were then incubated overnight at
4 °C in either panPMCA antibody (5F10; 1:5,000 dilution) or
in PMCA4 isoform-specific antibody (JA9; 1:1,000 dilution).
The vehicle in both cases was solution supplemented with
10%  normal  horse  serum  and  0.3%  TX.  Monoclonal
antibodies 5F10 and JA9 were a generous donation (Brent
Rolland,  Executive  Vice  President;  Affinity  BioReagents,
Inc., Golden, CO) and have been previously characterized
[49,55,56]. Sections were then washed three times in 0.1 M
PBS – 0.3% TX and incubated with Fluorescein (FITC)–
conjugated,  horse-anti-mouse  IgG  (1:100;  Vector
Laboratories) for 60 min at RT in a humidified chamber. After
a final wash, the slides were coverslipped with SlowFade
Mounting  Medium  (Molecular  Probes).  Negative  control
sections of CE were incubated with non-immunized mouse
IgG in place of the primary antibody.
Microscopy: Tissue sections were examined using a Leitz
Laborlux - S (Wetzlar, Germany) microscope fitted with an
FITC cube. Images were captured by epifluorescence using a
Magnifier  CCD  camera  (Olympus  America,  Inc.,  Center
Valley, PA) and Magnafire SP V1.0x5 (Optronics®, Goleta,
CA)  and  ImagePro®  Express  V4.0  (Media  Cybernetics,
Bethesda,  MD)  software,  and  processed  using  Adobe
Photoshop (Adobe Systems Incorporated, Orem, UT).
Early in this investigation, it was noted that the pattern of
PMCA4  expression  in  the  basal  epithelial  cell  plasma
membrane  of  wounded  CE  was  altered  compared  to  that
observed  in  control  basal  cells.  Therefore,  we  sought  to
quantify these changes in experimental corneas at each time
point  examined  during  the  wound  healing  process.  Three
zones were defined for this purpose (Figure 1). Zone 1 (wound
margin)  in  the  experimental  eye  was  defined  as  one
microscopic  field  of  view  (430  μm  in  diameter  at  a
magnification of 400×) beginning at the wound edge and
continuing peripherally across the CE. Zone 2 (juxtamarginal
zone) comprised the microscopic field of view lying two fields
of view peripheral to Zone 1. Zone 3 contained the limbus.
Equivalent  zones  were  defined  for  similar  regions  of  the
contralateral  (control)  eye.  The  only  Zone  where  marked
PMCA4 changes were observed was Zone 1, and these data
are presented here (Figure 2 and Figure 3). For the purposes
of this study, a basal cell in the wounded area was considered
to be any cell of any shape that was resting on the basal lamina.
The number of basal epithelial cells that stained positively for
PMCA4  immunoreactivity  [46]  in  the  apical  plasma
Figure  1.  Quantitation  of  plasma
membrane calcium-ATPase isoform 4
(PMCA4) expression in rabbit corneal
epithelium.  PMCA4  localization  in
basal  epithelial  cells  of  wounded  CE
(A) and control CE (B) was analyzed
quantitatively  with  reference  to  three
defined zones.
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2262Figure 2. Redistribution of plasma membrane calcium-ATPase isoform 4 (PMCA4) in basal epithelial cells at the wound margin during corneal
reepithelialization. The pattern of PMCA4 IR is shown in the wound margin at 6 h (A), 24 h (B), 36 h (C), and 48 h (D), and in the control
cornea at 6 h (E). The presence (asterisks) or absence (arrows) of basal plasma membrane staining in representative cells is shown (corneal
epithelium [CE]; stroma [S]). Bars in A represent 20 µm and apply to all panels.
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2263Figure 3. Quantitative analysis of plasma membrane calcium-ATPase isoform 4 (PMCA4) distribution in basal epithelial cells at the wound
margin during reepithelialization. The percentage of basal epithelial cells that exhibited PMCA4 staining in the apical plasma membrane,
basal plasma membrane and cytoplasm in wounded and control corneas at 6 h (A), 24 h (B), and 36 h (C) is shown. Note in particular, the
prominent redistribution of PMCA4 staining from apical to basal cell membranes in the wounded eye between 6 and 24 h as well as the increase
in cytoplasmic staining in wounded versus controls eyes at 6 and 24 h. The asterisk (*) represents a p value less than or equal to 0.01.
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2264membrane,  basal  plasma  membrane,  or  cytoplasm  were
counted for tissue sections from each wounded cornea and at
each time interval. For each animal, analysis was performed
on a minimum of three tissue sections from the wounded and
paired control eye. As noted above, the experiments were
repeated using 3 animals at the 6 h, 24 h, and 36 h post-
wounding time points. Two animals were examined at 48 h
post-wounding. Bar graphs in Figure 3 present the combined
data from three different animals at the 6 h, 24 h, and 36 h
post-wounding time points. The number of basal epithelial
cells that expressed each phenotype was calculated as the
percentage of the total number of basal cells in that zone.
RESULTS
Plasma membrane calcium-ATPase (PMCA) expression and
distribution in normal rabbit corneal epithelium: Western
blotting and PCR analysis were used to characterize PMCA4
expression in rbCE. In immunoblotting studies (Figure 4),
both the panPMCA and PMCA4 isoform-specific antibody
labeled an intense band at approximately 163 kDa. In rat
PMCA4  at  site  A,  a  36  bp  exon  can  undergo  alternative
splicing [38]. Direct sequencing of the site A product from
rbCE revealed that the 36 bp exon was inserted. Rabbit CE
thus expresses splice variant PMCA4x (designation is based
on  the  currently  accepted  nomenclature  as  described  by
Kamagate, et al. [38]). This sequence has 100% identity with
PMCA4x from human red blood cell (NCBI NM 001684.1)
and retinal pigment epithelium [51].
Immunohistochemical staining of normal rbCE with both
the  panPMCA  Ab  and  the  PMCA4  isoform-specific  Ab
revealed  strong  labeling  of  plasma  membranes  in  all  cell
layers and all regions of the CE (Figure 5). The corneal stroma
was unstained. The distributions of panPMCA IR and PMCA4
IR were similar with the notable exception that in a large
percentage  of  basal  epithelial  cells  PMCA4  staining  was
absent from these cells’ basal (i.e., stromal facing) plasma
membranes  (Figure  5B).  Immunohistochemical  control
sections incubated with nonimmunized mouse IgG in place of
primary Ab were unstained (Figure 5C).
Distributional changes in plasma membrane calcium-ATPase
isoform  four  (PMCA4)  expression  during  corneal
reepithelialization  of  injured  rabbit  corneal  epithelium:
Analysis of PMCA4 IR demonstrated substantial temporal
and spatial changes in PMCA4 distribution in basal epithelial
cells at the wound margin during corneal epithelial wound
healing. In contrast, the patterns of PMCA4 distribution basal
cells of the juxtamarginal zone and corneoscleral limbus were
unchanged from control corneas.
At  6  h  post  epithelial  wounding,  the  wound  margin
consisted  of  1  or  2  layers  of  cuboidal  or  squamous  cells
(Figure 2A). Approximately 83% of the basal cells located at
the wound margin demonstrated apical staining, compared to
100% of basal epithelial cells from the control eye in the same
animal treated with PBS (Figure 3A). Approximately 58% of
the basal cells in injured CE showed PMCA4 IR along the
basal membrane, compared to 32% of the basal cells in control
CE. Fifty percent of the marginal zone basal cells in wounded
CE contained cytoplasmic staining, as compared to only 13%
of basal cells in nonwounded CE.
At 24 h post wounding, the cells at the wound margin
comprised a monolayer of long, flattened cells (Figure 2B).
By 24 h following injury the percentages of basal cells that
showed  apical  or  basal  plasma  membrane  labeling  were
essentially reversed (Figure 3B). Approximately 46% of cells
at the wound margin demonstrated apical staining compared
to 89% of basal cells in the corresponding region of the control
cornea. Seventy-seven percent of cells in the area of the wound
margin  exhibited  IR  along  the  basal  cell  membrane,  as
compared to 25% in control CE. The percentage of basal cells
in  either  eye  that  demonstrated  cytoplasmic  PMCA4
immunoreactivity was relatively unchanged from 6 h.
At  36  h  post  injury,  the  wound  was  closed  and  the
previously  denuded  area  was  completely  covered  by  a
partially stratified epithelium consisting of 2–3 cell layers
(Figure  2C).  The  polarity  of  PMCA4  labeling  in  basal
epithelial cells had reversed from that seen at 24 h (Figure
2B,C) and began to more closely resemble that seen in normal
and control CE (Figure 2E). Eighty percent of the basal cells
in the area of the former wound margin showed apical staining
as compared to 96% of the cells in the comparable region of
the control cornea (Figure 3C). Forty-seven percent of basal
Figure  4.  Immunoblot  analysis  of  plasma  membrane  calcium-
ATPase (PMCA) in rabbit corneal epithelium. Blot lanes were loaded
with equal aliquots of whole cell lysate. The panPMCA antibody was
used at 0.65 mg/ml, and the PMCA4 antibody was used at 0.4 mg/
ml (data presented here is from a single animal and is representative
of  immunoblot  studies  of  the  CE  from  three  different  normal
animals).
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2265Figure 5. Localization of plasma membrane calcium-ATPase (PMCA) in rabbit corneal epithelium (CE). A: Immunostaining with pan-PMCA
antibody revealed strong PMCA labeling in all layers of the CE. The staining was associated primarily with the plasma membranes with
diffuse cytoplasmic staining in some cells. The corneal stroma (S) was unstained. B: The pattern and intensity of immunoreactivity seen with
PMCA4 isoform-specific antibody was similar to that seen with the panPMCA antibody, except that PMCA4 labeling is absent (arrows) from
most basal cell plasma membranes adjacent to the stroma. C: Control section incubated with nonimmune mouse IgG revealed an absence of
staining.
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2266cells in the formally denuded area and 12% of the basal cells
in  the  control  CE  demonstrated  basal  staining.  Finally,
approximately 27% of cells in the area of the former wound
area and 12% of those cells in the corresponding area of the
control cornea showed cytoplasmic PMCA4 labeling.
At 48 h post injury, the process of re-stratification had
continued to a point where the CE consisted of a well defined
layer of columnar-shaped basal cells, a layer of wing cells,
and 1–2 layers of flattened squamous cells (Figure 2D). The
plasma membranes of all the cells in all layers were positive
for  panPMCA  labeling  (data  not  shown).  The  pattern  of
PMCA4 staining in basal cells was indistinguishable from that
seen in basal cells in control CE and normal CE.
Effect of siRNAPMCA4 transfection on wound healing using the
hTCEpi cell line: An siRNA construct against exon 17 of
PMCA4 and a scrambled construct with no known homology
to any human mRNA were used to test the hypothesis that
knockdown of PMCA4 expression would adversely affect CE
wound healing. Overall, the rate of wound closure was slower
in  siRNAPMCA4  transfected  cultures  as  compared  to
siRNAScrambled transfected (control) cultures (Figure 6). Some
control cultures were completely healed as early as 21 h post-
injury, and all control cultures were healed between 24 and 27
h (Figure 6 and Figure 7). In contrast, in all siRNAPMCA4
transfected cultures CE cells failed to completely close the
wound defect at the maximum measured time point of 30 h
(Figure 6 and Figure 7E).
DISCUSSION
Plasma membrane calcium ATPase expression in the normal
rabbit CE: The results of this study have shown for the first
time, using three different methods (PCR, immunoblotting,
and immunohistochemistry) the presence of PMCA in the
normal rabbit corneal epithelium. The data mirror results from
our previous report of PMCA expression and distribution in
human  CE  [47],  as  well  as  data  from  other  investigators
reporting the presence of PMCA in rat [57], bovine [58], and
mouse CE [41]. Sequencing of the PCR DNA from rabbit
revealed that PMCA4x is the splice variant in rabbit CE at site
A. PMCA4x is the same splice variant expressed in human
corneal  epithelium  [47,48].  Immunohistochemical  staining
with a panPMCA antibody demonstrates that PMCAs are
expressed by all cells in the normal rabbit CE and limbus, and
that PMCAs are located mainly in the plasma membrane;
however, the presence in some cells of diffuse cytoplasmic
staining  suggests  that  some  PMCAs  are  associated  with
cytoplasmic membranes. It is suggested that that PMCAs, via
their  ability  to  extrude  intracellular  calcium  into  the
extracellular  space,  play  key  roles  in  critical  calcium-
dependent  cell  behaviors  in  this  continuously  renewing
epithelium including, proliferation, migration, adhesion, and
differentiation [20-25].
Redistribution of PMCA4 and possible functional roles for
PMCA4 during corneal epithelial wound healing: The data
presented in this investigation show that PMCA4 IR exhibited
a marked change in distribution of epithelial cells at the wound
margin during CE wound healing. In normal and control rabbit
corneal  epithelium,  PMCA4  IR  was  expressed  in  basal
epithelial  cells  in  a  strongly  “polarized”  fashion  with  the
isoform IR most prominent along the plasma membranes at
the apices and lateral plasma membranes of the basal cells and
weakly  (or  not  at  all  in  most  cells)  along  the  plasma
membranes facing the basal lamina. This polarity of PMCA4
immunostaining “reverses” during epithelial wound healing.
Figure  6.  Graphical  representation  of
rate  of  corneal  epithelial  cell  culture
wound  closure  in  siRNA  transfected
cultures. Wounded siRNAPMCA4 (blue)
transfected hTCEpi cells fail to close the
wound defect in monolayer of hTCEpi
cell cultures. hTCEpi cells transfected
with  siRNAScrambled  (red)  do  migrate
over  the  wounded  area  and  close  the
wound defect earlier than hTCEpi cells
where  PMCA4  expression  has  been
reduced. The asterisk (*) represents a p
value equal to 0.01.
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2267That is, the basal cells near the wound margin express more
PMCA4  along  the  basal  membrane  than  apically,  with  a
concurrent increase in cytoplasmic staining. This pattern of
IR then reverts back to control (or non-injured) conditions
soon after the denuded area is closed. A similar pattern of
protein redistribution in mouse CE was found for fodrin by
Takahashi et al. [59]. Fodrin is an actin-binding protein, and
forms a complex with E-cadherin, a Ca2+-dependent cell-cell
adhesion protein [60]. It is well known that the cytoskeleton
protein  actin  plays  a  major  role  in  cell  migration.  This
redistribution of fodrin and interaction with E-cadherin sets
the  stage  to  evaluate  the  possible  functional  role(s)/
interaction(s) of PMCA4 in cell migration and wound healing.
During the latent phase of wound healing, basal cells at
the wound margin undergo extensive cellular and subcellular
reorganization  including  loss  of  columnar  appearance,
increase in cell volume and breakdown of hemisdesmosomal
attachments to the stroma [10-13]. During the migration phase
of CE wound healing, cells at the leading edge of the wound
margin begin to migrate across the denuded area. These cells
pull  more  peripheral  cells  behind  them  as  a  continuous
epithelial sheet until the wound defect is covered [14-17]. We
hypothesize  that  the  redistribution  of  PMCA4  observed
during the migration phase may relate to altered Ca2+ needs
required for cell movement and changes in the stability of cell-
to-cell or cell-to-matrix junctions. For example, E-cadherin is
found in cell membranes of corneal epithelial cells [61]. In the
classical cadherin model, extracellular Ca2+ interacts within
pockets  located  in  E-cadherins  to  form  rigid  E-cadherin
dimers. Under the influence of additional Ca2+, these dimers
bind adjacent cells together by forming E-cadherin oligomers
[25]. PMCA4 may function to stabilize these adhesions by
pumping Ca2+ into the junctional spaces. In the present study,
PMCA4  redistributes  from  the  plasma  membrane  to  the
cytoplasm (Figure 2 and Figure 3); the resulting decrease in
extracellular Ca2+ available to interact with E-cadherin may
Figure 7. Photomicrograph of representative siRNA transfected hTCEpi cultures. This figure shows photomicrographs of representative siRNA
transfected hTCEpi cell cultures: (A) non-wounded; (B) wounded at 0 h post-wounding; (C), (D), and (E) are siRNAPMCA4 transfected cell
cultures at 6 h, 21 h, and 30 h post-wounding, respectively; (F), (G), and (H) are siRNAScrambled transfected cell cultures for the corresponding
respective time intervals. At 21 and 30 h post-wounding are siRNAPMCA4 CE cells fail to close the denuded (i.e., wounded) area as compared
to siRNAScrambled transfected cells where the wound is closed at 21 h. Bar in H represents 100 µm and applies to all panels.
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2268result in the more flexible cell-to-cell junctional complexes
needed for epithelial sheet migration. A prior study by Amino
et al. [41] yielded results compatible with this hypothesis.
These investigators demonstrated PMCAs redistribute from
cell membrane caveolae to cytoplasmic membranes during re-
epithelialization of mouse CE following wounding.
The finding that basal cells at the wound margin express
more PMCA4 in the basal plasma membrane than “control”
basal  cells  may  suggest  a  role  for  PMCA  in  cell-to-
extracellular matrix adhesion. Ca2+ in the ECM at the site of
focal adhesions interacts with calpain, which then cleaves
integrins  at  the  trailing  ends  of  migrating  cells  [20].  In
contrast,  intracellular  Ca2+  stabilizes  the  cytoplasmic
components  of  integrins  near  the  advancing  edges  of
migrating cells [20]. Thus, PMCA4 shifted to the basal plasma
membrane of migrating basal epithelial cells may help direct
these opposing processes. This idea gains support from one
study in which Brundage, et al. [62] demonstrated regional
changes  in  Ca2+  concentration  both  at  the  leading  and
retracting edges of migrating eosinophils. In the present study,
when  PMCA4  expression  was  knocked  down  via
siRNAPMCA4 transfection, migration slowed and cells failed to
close the wound defect within a comparable time interval to
control  cultures.  These  results  when  correlated  to  the
redistribuiton  of  PMCA4  to  the  portion  of  the  basal  cell
plasma membrane adjacent to the corneal stroma during cell
migration suggest of a role for PMCA4 in the regulation of
Ca2+-handling in the formation of cell-to-extracellular matrix
adhesion during migration. PMCA4 may also be involved
with  regulation  of  Ca2+-handling  needed  for  fodrin-actin
interaction during cell migration as indicated by the pattern of
fodrin  redistribution  during  CE  being  similar  to  that  of
PMCA4 in the present study [59].
The basal cells of CE are the only cells in CE that are
capable  of  a  mitogenic  or  proliferative  response.  CE
proliferation  (and  regeneration)  is  affected  by  a  host  of
cytokines,  such  as  epidermal  growth  factor  (EGF)  [4].
Following injury to CE, EGF synthesis increases and EGF
stimulates wound closure via a variety of signaling pathways,
including cascades that activate calcium transients [63]. More
recently,  canonical  transient  receptor  potential  protein
isoform TRPC4 knockdown has been shown to suppress EGF
- induced store-operated Ca2+ channel activation and growth
in human CE [64]. This suggests that TRPC4 expression is
required for EGF to be maximally effective through inositol
1,4,5  triphosphate  (IP3)  –linked  pathways.  Interestingly,
Sgambato-Fuare et al. [65], showed the interaction of the
Homer  scaffold  protein,  Homer-1/Ania-3,  with  PMCAs
suggesting coupling of PMCAs to IP3 receptor Ca2+ channels.
Taken  together  with  the  results  presented  herein,  it  is
reasonable to hypothesize a connection between TRPC4 and
PMCA via IP3 –linked pathways that may affect mitogenic
response in CE.
At the present time the nature of the mechanism that
results  in  a  shift  of  PMCA4  from  apical  to  basal  plasma
membranes  in  incompletely  understood.  However,  it  is
reasonable  to  suggest  that  alternative  splicing  of  PMCA4
primary transcripts may be involved. Support for this idea
comes  from  several  experimental  studies  showing  that
PMCAs may be “selectively” targeted to different areas of the
cell plasma membrane. Chicka et al. [66] have shown that
alternative  splicing  of  PMCA2  at  splice  site  A  (near  the
NH2-terminus  along  the  first  intracellular  loop)  alters  its
membrane targeting in MDCK (Madin-Darby Canine kidney
epithelial)  epithelial  cells.  These  data  demonstrated  that
alternative  splicing  at  the  A  site  involved  a  PDZ-protein
binding domain such that PMCA2w, containing the full length
spliced-in  insert  was  targeted  to  apical  and  basal  cell
membranes, but the PMCA2x and z variants, containing a
partial  insert  or  no  insert,  respectively,  were  selectively
targeted to the basal lateral membrane. Additional evidence
suggests that PMCA b-splice variants (at the C splice site)
interact with PMCA-interacting single PDZ protein for the
sorting of PMCAs to or from the plasma membrane [67,68].
This  is  interesting  in  that  in  prior  experiments  in  our
laboratory, human CE has been shown to express PMCA4x,b
[47,48];  here  in  this  investigation  rabbit  CE  expresses
PMCA4x  (the  C  splice  site  variant  in  rabbit  is  yet
undetermined). However, it is not clear at the present time if
a change in alternative splice variant expression occurs during
corneal epithelial wound healing.
This study shows that PMCA4 is strongly expressed in
rabbit corneal epithelium and that the pattern of PMCA4 IR
markedly changes during the process of corneal epithelial
wound healing. The functional significance of the change in
PMCA4 localization is not resolved by this study, however,
the results here suggest a role for PMCA4 in migration during
CE  wound  healing.  Most  certainly  Ca2+-handling
requirements  of  corneal  epithelial  cells  are  altered  during
reepithelialization, a process that comprises morphological
changes, migration, proliferation and differentiation. PMCA4
redistribution would allow the cells of the CE to maintain
different  “regional”  baseline  levels  of  [Ca2+]i  and  to
selectively respond to signals regulating [Ca2+]i and junctional
levels of Ca2+ during CE wound healing. To fully understand
calcium handling by the corneal epithelium during the wound
healing process, the transporters catalyzing calcium efflux
must  be  characterized.  The  present  work  has  begun  this
process by examining PMCA4 expression and distribution in
rabbit corneal epithelial wound healing, and the knockdown
of PMCA4 expression in corneal epithelial wound healing in
vitro. The stage is now set for additional studies to further
characterize the functional role(s) of each PMCA isoform in
wound  healing  of  stratified  epithelium.  These  functional
experiments  might  include  the  selective  knockdown  of
additional PMCA isoform expression in corneal epithelial
cells during adhesion and migration studies, and may also
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2269investigate possible interactions of PMCAs with fodrin, actin
and E-cadherins.
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